Form 4: Krystal Biotech's Chief Accounting Officer Exercises and Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Kathryn Romano, Chief Accounting Officer of Krystal Biotech, Inc., executed multiple transactions involving the exercise of stock options and the sale of common stock on February 28, 2024, under pre-arranged Rule 10b5-1 trading plans.
Summary
- On February 28, 2024, Kathryn Romano, the Chief Accounting Officer of Krystal Biotech, Inc., engaged in multiple transactions involving the company's common stock.
- These transactions included the exercise of stock options at a price of $63.55 per share and the subsequent sale of those shares at prices ranging from approximately $162.73 to $172.23.
- The sales were executed in multiple trades at varying prices, with weighted average sale prices reported for each set of transactions.
- These activities were conducted under two Rule 10b5-1 trading plans, which were adopted on August 29, 2023, and are set to terminate on June 28, 2024.
- One plan contemplates option exercises and sales of 2,500 shares with a limit price of $140.00 per share, while the other contemplates option exercises and sales of 5,000 shares with a limit price of $145.00 per share.
- Following these transactions, Romano directly owns 12,936 shares of Krystal Biotech common stock and holds options to purchase 35,000 shares.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity under a pre-arranged plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Future Outlook
The reporting person will continue to execute trades under the existing 10b5-1 trading plan until June 28, 2024.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Insiders often use Rule 10b5-1 trading plans to avoid accusations of trading on non-public information.
Key Dates
| Date | Description |
|---|---|
| 2023/02/28 | First vesting date of 50,000 options granted to Kathryn Romano. |
| 2023/08/29 | Date of adoption of the Rule 10b5-1 trading plans. |
| 2024/02/28 | Date of the reported transactions (option exercise and stock sale). |
| 2024/02/28 | Option exercisable and expiration date. |
| 2024/03/01 | Date of signature on the Form 4 filing. |
| 2024/06/28 | Termination date of the Rule 10b5-1 trading plans. |
| 2032/02/28 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.